Citius Pharmaceuticals
CTXR
CTXR
29 hedge funds and large institutions have $2.43M invested in Citius Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 11 increasing their positions, 9 reducing their positions, and 34 closing their positions.
Holders
29
Holders Change
-28
Holders Change %
-49.12%
% of All Funds
0.39%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
11
Reduced
9
Closed
34
Calls
$244K
Puts
$103K
Net Calls
+$141K
Net Calls Change
+$55K
Top Buyers
1 |
1
UBS Group
Zurich,
Switzerland
|
$110K |
2 |
2
Squarepoint
New York
|
$199K |
3 |
3
Fisher Asset Management
Camas,
Washington
|
$51.2K |
4 |
TRCT
4
Tower Research Capital (TRC)
New York
|
$32.8K |
5 |
IA
5
IFP Advisors
Tampa,
Florida
|
$32.8K |